A Type of Protein Can Help on Dealing with Cancer – CPE-delta N

Tuesday, 01 February 2011 18:21

Written by Julius

Scientists recently reported that high levels of a certain protein in cancer may indicate which particular tumors are likely to multiply and spread. This was revealed as a result of a new study of medicine and clinical investigation which showed that high levels of CPE-delta N (a form of protein) predicted with sharp accuracy whether a tumor moved on from its previous location in the body of patients diagnosed with liver cancer (and adrenal cancer). The accuracy was rated at ninety percent. This late development may hold the key to improving detection of cancer in people’s bodies.

As such, further testing on CPE-delta N will be conducted and it remains to be seen if in the years to come scientists will eventually be able to come up with ways to determine if tumors spread and even predict whether the tumor will recur in the same tissue or in other parts of the person’s body. As of this stage, there is no accurate way of determining such developments. Currently, doctors use the grade and stage of a tumor to find out the prognosis of a patient.

The recent development of the CPE-delta N’s ability to predict tumor movement has baffled or intrigued some members of the health and scientific community. Around the world there are groups of researchers who took samples from the bodies of cancer patients as well as patients diagnosed with pheochromocytoma (adrenal gland tumor) and continue to do studies in search of breakthroughs. It remains to be seen how long the studies will take.